Atlas Venture Opportunity Fund I, L.P.
SEC CIK 1759241 · EDGAR
BoughtSold
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Atlas Venture Opportunity Fund I, L.P. made no open-market trades at KYMR in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-13 | 2023-01-11+ | KYMR | Kymera Therapeutics, Inc. | Atlas Venture Opportunity Fund I, L.P. | 10% | S - Sale | $30.22 | -98.8K | 5.05M | -2% | -$2.99M |
| MI | 2023-01-13 | 2023-01-11+ | KYMR | Kymera Therapeutics, Inc. | Atlas Venture Opportunity Fund I, L.P. | 10% | S - Sale | $30.22 | -27.7K | 890.1K | -3% | -$835.9K |
| DMI | 2021-10-26 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | Atlas Venture Opportunity Fund I, L.P. | 10% | C - Cnv Deriv | — | +2.55M | 1.40M | New | — |
| DI | 2021-10-26 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | Atlas Venture Opportunity Fund I, L.P. | 10% | P - Purchase | $16.00 | +187.5K | 735.9K | +34% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations